All in all, our work highlights novel, detrimental biochemical aspects triggered by the pI switch occurring at the C terminal in the presence of ALS mutations, which starts a sequence of pathological events downstream KIF5A aggregation. The gene discussed is KIF5A; the disease is amyotrophic lateral sclerosis.